Navigation Links
Flagship Biosciences Partners with a Leading IHC CLIA Laboratory for Companion Diagnostics Service
Date:7/6/2010

Partnership with Vitro Molecular in histology and image analysis IHC biomarker development offers a complete companion diagnostics development service

(PRWEB) July 6, 2010 -- Flagship Biosciences LLC, a provider of digital pathology services, announced it has expanded its partnership with Vitro Molecular in Miami, Florida, to provide validated IHC companion diagnostic development capabilities. Vitro Molecular is a physician-owned, anatomic pathology specialty laboratory founded by Hadi Yaziji M.D. in 2007. Vitro provides routine and specialty anatomic pathology services to a loyal physician clientele in Florida and other States. The laboratory is well known for its excellence in histopathology, particularly IHC and other molecular tests. “Our pharmaceutical customers require a scalable histology operation with high levels of excellence and experience in immunohistochemistry,” said David Young, cofounder and president of Flagship Biosciences. “Quantitative image analysis techniques are strongly dependent on reproducible procedures in histology, and Dr. Hadi Yaziji and his team at Vitro Molecular have established themselves as leaders in high quality IHC testing. Dr. Yaziji’s strength in immunohistochemistry techniques, as demonstrated in his leadership of the Annual International Retreats on Applied Immunohistochemistry and Molecular Pathology, will be helpful to Flagship as we look to improve the reproducibility of molecular tissue-based testing.”

“We recognize the importance of whole slide analysis and computer histology pattern recognition in improving immunohistochemistry techniques. We are delighted to partner with Flagship Biosciences in working to ensure that their novel image analysis techniques utilize the best and most reproducible and scalable immunohistochemistry services,” stated Dr. Hadi Yaziji, founder and president of Vitro Molecular.

Flagship Biosciences LLC is a pathologist-owned company focused on utilizing whole slide scanning for quantitative pathology in pharmaceutical and device applications. An recent example of Flagship’s capabilities in companion diagnostics development of multiple IHC markers is their pathologists' work in the development of an epithelial-mesenchymal transition diagnostic test.

# # #

Read the full story at http://www.prweb.com/releases/2010/07/prweb4222034.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Active Innovations, Inc. Releases Version 8 of its Flagship Document Management Software Platform, infoRouter
2. HR Pharmaceuticals, Inc. to Launch and Showcase Flagship Product Line at the National Teaching Institute & Critical Care Nurses Exposition
3. Digital Pathology Services Firm Flagship Biosciences Appoints New CEO
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2009 Financial Results
5. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
6. Martek Biosciences and the National Center for Creative Aging Introduce New Brain Health Awareness Campaign, "Beautiful Minds: Finding Your Lifelong Potential"
7. Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of Alex Leaf Distinguished Scientist Award
8. New Speakers Announced for the 2010 Personalized Medicine Partnerships Conference
9. BABYCENTER Partners In Promoting Safe And Healthy Pregnancies Through Text4baby
10. Memory Loss Supplement Manufacturer Partners With Nationally-Syndicated Radio Host John Tesh
11. Royal Caribbean International and LimoRes.com Announce Exclusive Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Flagship Biosciences Partners with a Leading IHC CLIA Laboratory for Companion Diagnostics Service 
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... -- , , , WHEN: , ... , , , LOCATION: , , , Online, with free ... EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice President ... Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... is witnessing an exceptional era. Several new demand spaces, such as ...
Breaking Medicine Technology: